Wed, Apr 26, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers November 2012

Rules & Regulations - Recent UCITS developments that will impact emerging hedge fund managers

Lucy Frew

 

 

 

 

 

This article was authored by Lucy Frew, a senior financial services lawyer specialising in financial services regulation and investment management. She is Head of Investment Funds and Financial Regulation, London, at Gide Loyrette Nouel LLP, a law firm. She has extensive expertise in advising leading international financial institutions on complex UK and European financial services regulation and has frequently been involved in advising investment fund managers on establishing and obtaining regulatory authorisation for their businesses.

This article provides an overview of the key developments in UCITS investment restrictions that fund managers should take note of.

Recent UCITS developments will have lasting impact for those hedge fund managers offering their strategies in UCITS funds. There will also be ramifications for those with non-UCITS alternative investment funds ("AIFs") under the incoming AIFMD.

UCITS and AIFMD regulations are moving in harness with each other. Many recent UCITS developments arise from implementation of the AIFMD, itself borrowing heavily from UCITS provisions. When regulators focus on a particular area in the UCITS sphere, this indicates what may be coming for AIFs and vice versa.  Below are some key developments regarding UCITS investment restrictions which managers should note.

Background

Following the introduction of the UCIT......................

To view our full article please login

This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
New Managers
New Managers
New Managers

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Opalesque Exclusive: WBB enters buy-side with new healthcare long/short strategy[more]

    Benedicte Gravrand, Opalesque Geneva: WBB Securities, a US financial services firm and boutique investment bank since 2001, has a long history within the biotech industry. Managing partner Steve Brozak has been associated with biotech for the last 25-30 years, and was involved with some of the mo